{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T09:41:51Z","timestamp":1793094111152,"version":"4.5.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T00:00:00Z","timestamp":1631232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["MSH-141980"],"award-info":[{"award-number":["MSH-141980"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["16890"],"award-info":[{"award-number":["16890"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004489","name":"Mitacs","doi-asserted-by":"publisher","award":["IT08605"],"award-info":[{"award-number":["IT08605"]}],"id":[{"id":"10.13039\/501100004489","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Type 2 diabetes can be treated, and sometimes reversed, with dietary interventions; however, strategies to implement these interventions while addressing medication changes are lacking. We conducted a 12-week pragmatic, community-based parallel-group randomized controlled trial (ClinicalTrials.gov: NCT03181165) evaluating the effect of a low-carbohydrate (&lt;50\u2009g), energy-restricted diet (~850-1100\u2009kcal\/day; Pharm-TCR; n\u2009=\u200998) compared to treatment-as-usual (TAU; n\u2009=\u200990), delivered by community pharmacists, on glucose-lowering medication use, cardiometabolic health, and health-related quality of life. The Pharm-TCR intervention was effective in reducing the need for glucose-lowering medications through complete discontinuation of medications (35.7%; n\u2009=\u200935 vs. 0%; n\u2009=\u20090 in TAU; p\u2009&lt;\u20090.0001) and reduced medication effect score compared to TAU. These reductions occurred concurrently with clinically meaningful improvements in hemoglobin A1C, anthropometrics, blood pressure, and triglycerides (all p\u2009&lt;\u20090.0001). These data indicate community pharmacists are a viable and innovative option for implementing short-term nutritional interventions for people with type 2 diabetes, particularly when medication management is a safety concern.<\/jats:p>","DOI":"10.1038\/s41467-021-25667-4","type":"journal-article","created":{"date-parts":[[2021,9,10]],"date-time":"2021-09-10T06:03:22Z","timestamp":1631253802000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["A randomized controlled trial of pharmacist-led therapeutic carbohydrate and energy restriction in type 2 diabetes"],"prefix":"10.1038","volume":"12","author":[{"given":"Cody","family":"Durrer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"McKelvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"Singer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan M.","family":"Batterham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7523-9433","authenticated-orcid":false,"given":"James D.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey","family":"Gudmundson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Wortman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9796-2008","authenticated-orcid":false,"given":"Jonathan P.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,10]]},"reference":[{"key":"25667_CR1","doi-asserted-by":"publisher","first-page":"37","DOI":"10.7861\/clinmedicine.19-1-37","volume":"19","author":"R Taylor","year":"2019","unstructured":"Taylor, R. Calorie restriction for long-term remission of type 2 diabetes. Clin. Med. 19, 37\u201342 (2019).","journal-title":"Clin. Med."},{"key":"25667_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","volume":"31","author":"RD Feinman","year":"2015","unstructured":"Feinman, R. D. et al. Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base. Nutrition 31, 1\u201313 (2015).","journal-title":"Nutrition"},{"key":"25667_CR3","doi-asserted-by":"publisher","first-page":"m4743","DOI":"10.1136\/bmj.m4743","volume":"372","author":"JZ Goldenberg","year":"2021","unstructured":"Goldenberg, J. Z. et al. Efficacy and safety of low and very low carbohydrate diets for type 2 diabetes remission: systematic review and meta-analysis of published and unpublished randomized trial data. BMJ 372, m4743 (2021).","journal-title":"BMJ"},{"key":"25667_CR4","doi-asserted-by":"publisher","first-page":"e5","DOI":"10.2196\/diabetes.6981","volume":"2","author":"AL McKenzie","year":"2017","unstructured":"McKenzie, A. L. et al. A Novel Intervention Including Individualized Nutritional Recommendations Reduces Hemoglobin A1c Level, Medication Use, and Weight in Type 2 Diabetes. JMIR Diabetes 2, e5 (2017).","journal-title":"JMIR Diabetes"},{"key":"25667_CR5","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s13300-018-0373-9","volume":"9","author":"SJ Hallberg","year":"2018","unstructured":"Hallberg, S. J. et al. Effectiveness and safety of a novel care model for the management of type 2 diabetes at 1 year: an open-label, non-randomized, controlled study. Diabetes Ther. 9, 583\u2013612 (2018).","journal-title":"Diabetes Ther."},{"key":"25667_CR6","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3389\/fendo.2019.00348","volume":"10","author":"SJ Athinarayanan","year":"2019","unstructured":"Athinarayanan, S. J. et al. Long-term effects of a novel continuous remote care intervention including nutritional ketosis for the management of type 2 diabetes: a 2-year non-randomized clinical. Trial Front. Endocrinol. 10, 348 (2019).","journal-title":"Trial Front. Endocrinol."},{"key":"25667_CR7","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","volume":"391","author":"ME Lean","year":"2018","unstructured":"Lean, M. E. et al. Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial. Lancet 391, 541\u2013551 (2018).","journal-title":"Lancet"},{"key":"25667_CR8","doi-asserted-by":"crossref","unstructured":"Saslow, L. R. et al. An online intervention comparing a very low-carbohydrate ketogenic diet and lifestyle recommendations versus a plate method diet in overweight individuals with type 2 diabetes: a randomized controlled trial. J. Med. Internet Res. 19, e36 (2017).","DOI":"10.2196\/jmir.5806"},{"key":"25667_CR9","doi-asserted-by":"publisher","first-page":"e209132","DOI":"10.1001\/jamanetworkopen.2020.9132","volume":"3","author":"LA Berenbrok","year":"2020","unstructured":"Berenbrok, L. A., Gabriel, N., Coley, K. C. & Hernandez, I. Evaluation of frequency of encounters with primary care physicians vs visits to community pharmacies among medicare beneficiaries. JAMA Netw. open 3, e209132 (2020).","journal-title":"JAMA Netw. open"},{"key":"25667_CR10","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1345\/aph.17095","volume":"32","author":"EA Coast-Senior","year":"1998","unstructured":"Coast-Senior, E. A., Kroner, B. A., Kelley, C. L. & Trilli, L. E. Management of patients with type 2 diabetes by pharmacists in primary care clinics. Ann. Pharmacother. 32, 636\u2013641 (1998).","journal-title":"Ann. Pharmacother."},{"key":"25667_CR11","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1080\/17446651.2018.1523713","volume":"13","author":"EC Westman","year":"2018","unstructured":"Westman, E. C. et al. Implementing a low-carbohydrate, ketogenic diet to manage type 2 diabetes mellitus. Expert Rev. Endocrinol. Metab. 13, 263\u2013272 (2018).","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"25667_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-019-3873-7","volume":"20","author":"C Durrer","year":"2019","unstructured":"Durrer, C. et al. Pharmacist-led therapeutic carbohydrate restriction as a treatment strategy for type 2 diabetes: the Pharm-TCR randomized controlled trial protocol. Trials 20, 781 (2019).","journal-title":"Trials"},{"key":"25667_CR13","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1016\/j.jcjd.2017.10.034","volume":"42","author":"L Lipscombe","year":"2018","unstructured":"Lipscombe, L. et al. Pharmacologic glycemic management of type 2 diabetes in adults. Can. J. Diabetes 42, S88\u2013S103 (2018).","journal-title":"Can. J. Diabetes"},{"key":"25667_CR14","unstructured":"International Diabetes Federation. IDF Diabetes Atlas, 9th edn. https:\/\/www.diabetesatlas.org\/en\/ (2019)."},{"key":"25667_CR15","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1055\/s-2005-861411","volume":"37","author":"C Thamer","year":"2005","unstructured":"Thamer, C. et al. Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids. Horm. Metab. Res. 37, 246\u2013251 (2005).","journal-title":"Horm. Metab. Res."},{"key":"25667_CR16","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/S0002-8703(99)70312-1","volume":"138","author":"J He","year":"1999","unstructured":"He, J. & Whelton, P. K. Elevated systolic blood pressure and risk of cardiovascular and renal disease: overview of evidence from observational epidemiologic studies and randomized controlled trials. Am. Heart J. 138, 12\u201317 (1999).","journal-title":"Am. Heart J."},{"key":"25667_CR17","first-page":"S5","volume":"21","author":"LF Van Gaal","year":"1997","unstructured":"Van Gaal, L. F., Wauters, M. A. & De Leeuw, I. H. The beneficial effects of modest weight loss on cardiovascular risk factors. Int. J. Obes. Relat. Metab. Disord. 21, S5\u2013S9 (1997). Suppl 1.","journal-title":"Int. J. Obes. Relat. Metab. Disord."},{"key":"25667_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/sj.ijo.0800377","volume":"21","author":"TS Han","year":"1997","unstructured":"Han, T. S., Richmond, P., Avenell, A. & Lean, M. E. J. Waist circumference reduction and cardiovascular benefits during weight loss in women. Int. J. Obes. 21, 127\u2013134 (1997).","journal-title":"Int. J. Obes."},{"key":"25667_CR19","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"M Miller","year":"2011","unstructured":"Miller, M. et al. Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association. Circulation 123, 2292\u20132333 (2011).","journal-title":"Circulation"},{"key":"25667_CR20","doi-asserted-by":"publisher","first-page":"e230","DOI":"10.1038\/nutd.2016.36","volume":"6","author":"A Goday","year":"2016","unstructured":"Goday, A. et al. Short-term safety, tolerability and efficacy of a very low-calorie-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutr. Diabetes 6, e230\u2013e230 (2016).","journal-title":"Nutr. Diabetes"},{"key":"25667_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/dom.13915","volume":"22","author":"E Morris","year":"2020","unstructured":"Morris, E. et al. A food\u2010based, low\u2010energy, low\u2010carbohydrate diet for people with type 2 diabetes in primary care: a randomized controlled feasibility trial. Diabetes, Obes. Metab. 22, 512\u2013520 (2020).","journal-title":"Diabetes, Obes. Metab."},{"key":"25667_CR22","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1111\/dom.12971","volume":"19","author":"A Gummesson","year":"2017","unstructured":"Gummesson, A., Nyman, E., Knutsson, M. & Karpefors, M. Effect of weight reduction on glycated haemoglobin in weight loss trials in patients with type 2 diabetes. Diabetes, Obes. Metab. 19, 1295\u20131305 (2017).","journal-title":"Diabetes, Obes. Metab."},{"key":"25667_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1743-7075-3-22","volume":"3","author":"JV Nielsen","year":"2006","unstructured":"Nielsen, J. V. & Joensson, E. Low-carbohydrate diet in type 2 diabetes. Stable improvement of bodyweight and glycemic control during 22 months follow-up. Nutr. Metab. (Lond.). 3, 22 (2006).","journal-title":"Nutr. Metab. (Lond.)."},{"key":"25667_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","volume":"7","author":"MEJ Lean","year":"2019","unstructured":"Lean, M. E. J. et al. Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial. Lancet Diabetes Endocrinol. 7, 344\u2013355 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"25667_CR25","doi-asserted-by":"publisher","first-page":"16","DOI":"10.4103\/2347-9906.148605","volume":"2","author":"S Ravindra","year":"2015","unstructured":"Ravindra, S. & Miras, A. Moving goal posts: definition of diabetes remission after bariatric surgery. J. Obes. Metab. Res 2, 16 (2015).","journal-title":"J. Obes. Metab. Res"},{"key":"25667_CR26","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse, J. B. et al. How do we define cure of diabetes? Diabetes Care 32, 2133\u20132135 (2009).","journal-title":"Diabetes Care"},{"key":"25667_CR27","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","volume":"7","author":"R Taylor","year":"2019","unstructured":"Taylor, R., Al-Mrabeh, A. & Sattar, N. Understanding the mechanisms of reversal of type 2 diabetes. Lancet Diabetes Endocrinol. 7, 726\u2013736 (2019).","journal-title":"Lancet Diabetes Endocrinol."},{"key":"25667_CR28","doi-asserted-by":"publisher","first-page":"e013096","DOI":"10.1136\/bmjopen-2016-013096","volume":"6","author":"CJ Coffman","year":"2016","unstructured":"Coffman, C. J., Edelman, D. & Woolson, R. F. To condition or not condition? Analysing \u2018change\u2019 in longitudinal randomised controlled trials. BMJ Open 6, e013096 (2016).","journal-title":"BMJ Open"},{"key":"25667_CR29","first-page":"18","volume":"4","author":"G Godin","year":"2011","unstructured":"Godin, G. The godin-shephard leisure-time physical activity questionnaire. Heal. Fit. J. Can. 4, 18\u201322 (2011).","journal-title":"Heal. Fit. J. Can."},{"key":"25667_CR30","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1097\/00005650-198807000-00007","volume":"26","author":"AL Stewart","year":"1988","unstructured":"Stewart, A. L., Hays, R. D. & Ware, J. E. The MOS short-form general health survey: reliability and validity in a patient population. Med. Care 26, 724\u2013735 (1988).","journal-title":"Med. Care"},{"key":"25667_CR31","first-page":"174239531988409","volume":"0","author":"A-S Alexopoulos","year":"2019","unstructured":"Alexopoulos, A.-S. et al. Clinical associations of an updated medication effect score for measuring diabetes treatment intensity. Chronic Illn. 0, 174239531988409 (2019).","journal-title":"Chronic Illn."},{"key":"25667_CR32","unstructured":"R Core Team. R: A Language and Environment for Statistical Computing. https:\/\/www.r-project.org\/ (2020)."},{"key":"25667_CR33","unstructured":"StataCorp. Stata Statistical Software: Release 16. (2019)."},{"key":"25667_CR34","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1177\/1536867X1301300402","volume":"13","author":"RB Newson","year":"2013","unstructured":"Newson, R. B. Attributable and unattributable risks and fractions and other scenario comparisons. Stata J. 13, 672\u2013698 (2013).","journal-title":"Stata J."},{"key":"25667_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v067.i01","volume":"67","author":"D Bates","year":"2015","unstructured":"Bates, D., Maechler, M., Bolker, B. & Walker, S. Fitting linear mixed-effects models using lme4. J. Stat. Softw. 67, 1\u201348 (2015).","journal-title":"J. Stat. Softw."},{"key":"25667_CR36","unstructured":"Lenth, R. emmeans: Estimated Marginal Means, aka Least-Squares Means. (2020)."},{"key":"25667_CR37","doi-asserted-by":"publisher","unstructured":"Davison, A. C. & Hinkley, D. V. Bootstrap Methods and their Application. Cambridge Series in Statistical and Probabilistic Mathematics (Cambridge University Press, 1997). https:\/\/doi.org\/10.1017\/CBO9780511802843.","DOI":"10.1017\/CBO9780511802843"},{"key":"25667_CR38","unstructured":"Canty, A. & Ripley, B. boot: Bootstrap R (S-Plus) Functions. (2020)."},{"key":"25667_CR39","unstructured":"NCSS LLC. PASS 14 Power Analysis and Sample Size Software. https:\/\/www.ncss.com\/software\/pass\/ (2015)."}],"updated-by":[{"DOI":"10.1038\/s41467-022-30330-7","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T00:00:00Z","timestamp":1651708800000}}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25667-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25667-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T09:27:19Z","timestamp":1669973239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-021-25667-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,10]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["25667"],"URL":"https:\/\/doi.org\/10.1038\/s41467-021-25667-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,10]]},"assertion":[{"value":"26 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2022","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41467-022-30330-7","URL":"https:\/\/doi.org\/10.1038\/s41467-022-30330-7","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.L. holds founder shares and advises for Metabolic Insights Inc., and is volunteer Chief Scientific Officer for the not-for-profit Institute for Personalized Therapeutic Nutrition. S.M. is employed as Chief Executive Officer for the not-for-profit Institute for Personalized Therapeutic Nutrition. J.W. is a member of the Scientific Advisory Board, and has received travel support and speaker\u2019s honoraria, from Atkins Nutritionals Inc. J.D.J. is Chair of the Board for the Institute for Personalized Therapeutic Nutrition and receives no compensation. C.D., J.S., A.M.B., and K.G. have nothing to declare.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5367"}}